My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.620 -0.070 (-4.14%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2 3 4 5 Next >

The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid ↗

April 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

April 29, 2022

Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per...

Via Benzinga

Innate Pharma FY 2021 Earnings Conference Call On March 24, 2022 At 09:00 AM ET ↗

March 22, 2022

Innate Pharma (NASDAQ:IPHA) will host a conference call at 09:00 AM ET on March 24, 2022, to discuss FY 2021 earnings results. How to Attend Innate Pharma (IPHA) Conference Call...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 10, 2022

Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6...

Via Benzinga

Earnings Scheduled For March 24, 2022 ↗

March 24, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 07, 2022

Gainers

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

January 25, 2022

Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets ↗

January 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...

Via Benzinga

18 Stocks Moving in Monday's Pre-Market Session ↗

January 03, 2022

Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI...

Via Benzinga

Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity ↗

December 09, 2021

Innate Pharma SA's (NASDAQ: IPHA) data from the Phase 2 expansion cohort (cohort 3) evaluating the monalizumab triplet combination shows preliminary activity and an...

Via Benzinga

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO ↗

December 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 25, 2021

Gainers Medpace Hldgs (NASDAQ:MEDP) shar...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 30, 2021

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion....

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

September 30, 2021

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 22, 2021

Check out these big penny stock gainers and losers Losers Edesa Biotech, Inc. (NASDAQ: EDSA) shares dipped 29.9% to close at $8.36 on profit-taking after the stock...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 21, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

32 Stocks Moving In Tuesday's Mid-Day Session ↗

September 21, 2021

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with Amazon Italy, a unit of Amazon.com. ReWalk...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers Viridian Therapeutics (NASDAQ:VRDN) shares rose 18.05% to $12.62 during Tuesday's pre-market session. The company's market cap stands at $120.9 million....

Via Benzinga

18 Stocks Moving in Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet ↗

September 17, 2021

Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to 4,435.65. The U.S. has...

Via Benzinga

Topics Stocks

Here's Why Innate Pharma Stock Is Rocketing Higher Today ↗

September 17, 2021

A clinical trial with an experimental lung cancer drug produced some positive results.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS

Via Benzinga

Mid-Day Market Update: Crude Oil Falls Over 1%; Helbiz Shares Spike Higher ↗

September 17, 2021

Midway through trading Friday, the Dow traded down 0.51% to 34,572.50 while the NASDAQ fell 0.78% to 15,062.99. The S&P also fell, dropping 0.72% to 4,441.64. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Morning Market Update: Markets Down; US Consumer Sentiment Edges Higher ↗

September 17, 2021

Following the market opening Friday, the Dow traded down 0.37% to 34,622.25 while the NASDAQ fell 0.58% to 15,094.19. The S&P also fell, dropping 0.55% to 4,449.03. The U.S....

Via Benzinga

Topics Stocks

What Is Happening With Innate Pharma Stock On Friday? ↗

September 17, 2021

Innate Pharma SA (NASDAQ: IPHA) stock is trading at a 52-week high as its partner AstraZeneca Plc (NASDAQ: AZN) presented results from the COAST Phase 2 trial...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 53.98% to $3.48 during Friday's pre-market session. The company's market cap stands at $147.6...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.